VIBEGRON

VIBEGRON was reported 8828 times

VIBEGRON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ROTATOR CUFF TEAR ARTHROPATHY 6 0.3529
1 BLADDER CATHETER REPLACEMENT 2 0.0833
2 URETHRAL SPASM 4 0.0769
3 ALLERGY TO SYNTHETIC FABRIC 2 0.0645
4 PELVIC OPERATION 4 0.0606
5 TENDINOUS CONTRACTURE 6 0.0526
6 INABILITY TO AFFORD MEDICATION 266 0.0268
7 RESIDUAL URINE VOLUME INCREASED 3 0.0254
8 URINARY STRAINING 3 0.0216
9 HEART FAILURE WITH PRESERVED EJECTION FRACTION 6 0.0204
10 DRUG EFFECT LESS THAN EXPECTED 285 0.0192
11 INSTILLATION SITE DISCHARGE 5 0.0190
12 PELVIC FLOOR DYSFUNCTION 4 0.0189
13 LOSS OF BLADDER SENSATION 3 0.0184
14 URINARY RETENTION POSTOPERATIVE 3 0.0182
15 NOCTURIA 208 0.0171
16 AUTOMATIC BLADDER 2 0.0145
17 THERAPEUTIC PRODUCT EFFECT VARIABLE 56 0.0144
18 BLADDER SPASM 27 0.0144
19 HYPERTONIC BLADDER 41 0.0142
20 TYPE IIA HYPERLIPIDAEMIA 3 0.0128
21 BLOOD FOLATE INCREASED 2 0.0120
22 PLEUROTHOTONUS 10 0.0111
23 URINARY HESITATION 26 0.0109
24 URINE FLOW DECREASED 26 0.0109
25 PRODUCT INFORMATION CONTENT COMPLAINT 3 0.0108
26 MICTURITION URGENCY 115 0.0101
27 URINARY RETENTION 335 0.0100
28 BLADDER PAIN 30 0.0094
29 RENAL STONE REMOVAL 5 0.0090
30 BLADDER DISCOMFORT 11 0.0088
31 PEPTIC ULCER HAEMORRHAGE 6 0.0086
32 URINARY INCONTINENCE 232 0.0078
33 BLADDER IRRITATION 5 0.0078
34 BLADDER OPERATION 9 0.0077
35 STRESS URINARY INCONTINENCE 8 0.0074
36 PERSISTENT DEPRESSIVE DISORDER 3 0.0074
37 FRACTURE PAIN 4 0.0074
38 THERAPEUTIC PRODUCT EFFECT DELAYED 33 0.0072
39 PRODUCT AVAILABILITY ISSUE 164 0.0072
40 URGE INCONTINENCE 6 0.0069
41 URETHRAL PAIN 4 0.0068
42 PRODUCT APPEARANCE CONFUSION 6 0.0065
43 ACTIVITIES OF DAILY LIVING DECREASED 4 0.0063
44 BLADDER CATHETERISATION 6 0.0062
45 TRANSURETHRAL PROSTATECTOMY 3 0.0060
46 DEFAECATION DISORDER 4 0.0060
47 BACTERIAL PYELONEPHRITIS 2 0.0060
48 CRANIOFACIAL FRACTURE 5 0.0058
49 CYSTOCELE 5 0.0058
50 ANION GAP DECREASED 2 0.0057
51 JOINT CONTRACTURE 6 0.0056
52 DEMENTIA WITH LEWY BODIES 6 0.0054
53 POLLAKIURIA 222 0.0053
54 ENURESIS 21 0.0052
55 INCONTINENCE 54 0.0051
56 THERAPEUTIC PROCEDURE 7 0.0050
57 RENAL SURGERY 3 0.0046
58 BLADDER HYPERTROPHY 2 0.0045
59 CYSTITIS INTERSTITIAL 7 0.0043
60 SHOULDER FRACTURE 7 0.0043
61 PERINEAL PAIN 3 0.0042
62 PRODUCT AFTER TASTE 4 0.0042
63 BLADDER DISORDER 41 0.0041
64 NORMOCYTIC ANAEMIA 6 0.0041
65 GENITAL PAIN 6 0.0041
66 DYSURIA 143 0.0039
67 THERAPEUTIC PRODUCT EFFECT DECREASED 173 0.0039
68 SKIN NEOPLASM EXCISION 3 0.0038
69 SINUS NODE DYSFUNCTION 7 0.0038
70 VITAMIN B12 INCREASED 3 0.0038
71 LIP ERYTHEMA 3 0.0038
72 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 4 0.0037
73 BLOOD LOSS ANAEMIA 8 0.0035
74 PERIARTHRITIS 8 0.0035
75 LIP PRURITUS 3 0.0035
76 BLOOD CHLORIDE INCREASED 6 0.0035
77 GENITAL BURNING SENSATION 3 0.0035
78 VASCULAR DEMENTIA 3 0.0034
79 HEART VALVE REPLACEMENT 5 0.0034
80 THORACIC VERTEBRAL FRACTURE 10 0.0034
81 PROSTATIC OPERATION 4 0.0033
82 SLEEP DEFICIT 7 0.0033
83 PRODUCT COLOUR ISSUE 17 0.0033
84 PRODUCT SHAPE ISSUE 3 0.0032
85 PELVIC DISCOMFORT 3 0.0032
86 MICTURITION DISORDER 11 0.0032
87 BLOOD BICARBONATE DECREASED 6 0.0032
88 INFUSION SITE NODULE 3 0.0031
89 THERAPY INTERRUPTED 223 0.0031
90 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 218 0.0031
91 SHOULDER ARTHROPLASTY 8 0.0030
92 EYE COLOUR CHANGE 3 0.0029
93 INFUSION SITE RASH 4 0.0029
94 PRODUCT CONTAINER SEAL ISSUE 5 0.0029
95 NEUROGENIC BLADDER 6 0.0028
96 BLOOD SODIUM ABNORMAL 3 0.0028
97 TERMINAL INSOMNIA 5 0.0028
98 ANAL INCONTINENCE 25 0.0028
99 INFUSION SITE MASS 3 0.0028
100 UTERINE PROLAPSE 3 0.0028
101 BLADDER DILATATION 3 0.0028
102 ESSENTIAL HYPERTENSION 5 0.0027
103 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 2 0.0027
104 DENTAL CARE 5 0.0027
105 INFUSION SITE INDURATION 4 0.0027
106 THERAPEUTIC PRODUCT EFFECT INCREASED 3 0.0026
107 FAECES HARD 10 0.0026
108 MEDICAL DEVICE IMPLANTATION 4 0.0025
109 GRANULOMATOSIS WITH POLYANGIITIS 3 0.0025
110 EYELID PAIN 5 0.0025
111 BALANOPOSTHITIS 2 0.0024
112 STERNAL FRACTURE 3 0.0024
113 MEDICAL PROCEDURE 4 0.0024
114 PRODUCT DISPENSING ERROR 52 0.0024
115 HYPERAESTHESIA TEETH 3 0.0024
116 SLEEP TALKING 4 0.0024
117 PRODUCT PACKAGING DIFFICULT TO OPEN 6 0.0023
118 URINARY TRACT INFECTION 392 0.0023
119 PROSTATOMEGALY 9 0.0023
120 VULVOVAGINAL CANDIDIASIS 3 0.0022
121 CATHETER PLACEMENT 4 0.0022
122 INFUSION SITE INFECTION 5 0.0021
123 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
124 INTENTIONAL UNDERDOSE 15 0.0021
125 BLOOD IRON ABNORMAL 2 0.0020
126 GENERALISED ANXIETY DISORDER 3 0.0020
127 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
128 HIP SURGERY 11 0.0020
129 RHINORRHOEA 131 0.0020
130 NEPHRECTOMY 3 0.0020
131 URINE ABNORMALITY 9 0.0020
132 URINARY TRACT INFECTION BACTERIAL 5 0.0020
133 HAEMORRHAGE URINARY TRACT 5 0.0020
134 BOWEL MOVEMENT IRREGULARITY 15 0.0020
135 PNEUMONIA PSEUDOMONAL 3 0.0020
136 BLADDER DYSFUNCTION 2 0.0019
137 DRY MOUTH 157 0.0019
138 URINE OUTPUT INCREASED 5 0.0019
139 SKIN ABRASION 9 0.0019
140 URINARY BLADDER HAEMORRHAGE 4 0.0019
141 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
142 SPINAL OPERATION 23 0.0019
143 TENSION HEADACHE 8 0.0019
144 DYSPHEMIA 8 0.0018
145 ARTHROPOD STING 3 0.0018
146 AORTIC DILATATION 2 0.0018
147 RHINOVIRUS INFECTION 7 0.0018
148 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
149 HOT FLUSH 132 0.0017
150 MILIARIA 3 0.0017
151 LUMBAR SPINAL STENOSIS 5 0.0017
152 URINARY TRACT OBSTRUCTION 4 0.0017
153 BILE DUCT CANCER 2 0.0017
154 SKIN WEEPING 6 0.0017
155 COMPRESSION FRACTURE 9 0.0017
156 TONGUE DISCOMFORT 7 0.0016
157 PENILE PAIN 5 0.0016
158 OESOPHAGEAL SPASM 3 0.0016
159 KNEE OPERATION 16 0.0016
160 URINE OUTPUT DECREASED 14 0.0016
161 BRAIN FOG 25 0.0016
162 EYELID IRRITATION 4 0.0016
163 INFUSION SITE PRURITUS 5 0.0016
164 VULVOVAGINAL PRURITUS 8 0.0016
165 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
166 PHYSICAL DECONDITIONING 4 0.0016
167 REHABILITATION THERAPY 6 0.0015
168 IMMUNE-MEDIATED HEPATIC DISORDER 3 0.0015
169 URINE ODOUR ABNORMAL 9 0.0015
170 FAECES SOFT 11 0.0015
171 EAR CONGESTION 4 0.0015
172 VULVOVAGINAL BURNING SENSATION 9 0.0015
173 B-LYMPHOCYTE COUNT DECREASED 2 0.0015
174 MIDDLE INSOMNIA 27 0.0014
175 CYSTITIS 46 0.0014
176 THERAPEUTIC RESPONSE DELAYED 4 0.0014
177 BLOOD URINE PRESENT 27 0.0014
178 FOOT OPERATION 7 0.0014
179 APPENDIX DISORDER 2 0.0014
180 AUDITORY DISORDER 2 0.0014
181 CATHETER SITE ERYTHEMA 3 0.0014
182 INFUSION SITE BRUISING 3 0.0014
183 EYELID MARGIN CRUSTING 4 0.0014
184 UPPER RESPIRATORY TRACT CONGESTION 4 0.0014
185 SENSITIVE SKIN 10 0.0014
186 URINARY TRACT DISORDER 6 0.0013
187 HALLUCINATION, VISUAL 28 0.0013
188 DYSCHEZIA 4 0.0013
189 ORAL PRURITUS 3 0.0013
190 PRODUCT DOSE OMISSION IN ERROR 37 0.0013
191 OVERWEIGHT 7 0.0013
192 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 8 0.0013
193 PRURITUS GENITAL 3 0.0013
194 VOLVULUS 3 0.0013
195 PUSTULE 3 0.0013
196 ON AND OFF PHENOMENON 7 0.0013
197 SINUS OPERATION 3 0.0013
198 OXYGEN CONSUMPTION INCREASED 3 0.0013
199 MYASTHENIA GRAVIS 10 0.0012
200 PERIORBITAL SWELLING 7 0.0012
201 FRUSTRATION TOLERANCE DECREASED 10 0.0012
202 DIZZINESS POSTURAL 12 0.0012
203 HAEMATOLOGICAL INFECTION 3 0.0012
204 GLOMERULAR FILTRATION RATE DECREASED 15 0.0012
205 INFUSION SITE HAEMORRHAGE 4 0.0012
206 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
207 SPINAL STENOSIS 5 0.0012
208 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
209 BLOOD PRESSURE ABNORMAL 24 0.0012
210 CONSTIPATION 263 0.0012
211 ILLNESS 124 0.0012
212 CATARACT OPERATION 7 0.0012
213 INSURANCE ISSUE 18 0.0012
214 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
215 INITIAL INSOMNIA 12 0.0012
216 INFUSION SITE PAIN 15 0.0012
217 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 209 0.0012
218 HORDEOLUM 5 0.0012
219 HERNIA REPAIR 3 0.0012
220 HYSTERECTOMY 10 0.0012
221 SEASONAL ALLERGY 16 0.0011
222 NASAL DISORDER 3 0.0011
223 WHEELCHAIR USER 5 0.0011
224 DRY EYE 56 0.0011
225 PRODUCT SIZE ISSUE 6 0.0011
226 WEIGHT BEARING DIFFICULTY 3 0.0011
227 INFUSION SITE SWELLING 7 0.0011
228 ANORGASMIA 3 0.0011
229 FAECALOMA 6 0.0011
230 KNEE ARTHROPLASTY 23 0.0011
231 DEMENTIA 30 0.0011
232 NASAL CONGESTION 63 0.0011
233 INFUSION SITE ERYTHEMA 9 0.0011
234 OXYGEN SATURATION ABNORMAL 3 0.0011
235 JOINT LOCK 3 0.0011
236 RESPIRATORY SYMPTOM 3 0.0011
237 HALLUCINATION 79 0.0010
238 THYROID MASS 4 0.0010
239 LIMB OPERATION 5 0.0010
240 ARTERIAL THROMBOSIS 2 0.0010
241 PRODUCT LABEL ISSUE 7 0.0010
242 MULTIPLE ALLERGIES 8 0.0010
243 INTENTIONAL DOSE OMISSION 29 0.0010
244 PRODUCT USE COMPLAINT 16 0.0010
245 HYPERVOLAEMIA 5 0.0010
246 SKIN LACERATION 11 0.0010
247 SINUS DISORDER 20 0.0010
248 ACCIDENT 12 0.0010
249 INFUSION SITE REACTION 3 0.0010
250 SYMPTOM RECURRENCE 6 0.0010
251 HYPOACUSIS 43 0.0010
252 MUSCULOSKELETAL DISCOMFORT 17 0.0010
253 EYE PAIN 55 0.0010
254 DIASTOLIC DYSFUNCTION 3 0.0010
255 PRODUCT DISTRIBUTION ISSUE 9 0.0010
256 NIGHT SWEATS 31 0.0010
257 SURGERY 56 0.0010
258 HALLUCINATIONS, MIXED 4 0.0010
259 RENAL PAIN 10 0.0009
260 SHOULDER OPERATION 4 0.0009
261 BODY HEIGHT DECREASED 10 0.0009
262 STUPOR 3 0.0009
263 PRODUCT CONTAINER ISSUE 8 0.0009
264 ABNORMAL SENSATION IN EYE 4 0.0009
265 BRUXISM 5 0.0009
266 POSTURE ABNORMAL 3 0.0009
267 NEAR DEATH EXPERIENCE 3 0.0009
268 DRUG INEFFECTIVE 1194 0.0009
269 CYSTIC FIBROSIS 5 0.0009
270 CATHETERISATION CARDIAC 4 0.0009
271 THIRST 16 0.0009
272 PRODUCT USE ISSUE 168 0.0009
273 POSTOPERATIVE WOUND INFECTION 6 0.0009
274 SINUS CONGESTION 12 0.0009
275 SKIN HAEMORRHAGE 13 0.0009
276 RIB FRACTURE 18 0.0009
277 EAR DISORDER 4 0.0009
278 LUMBAR VERTEBRAL FRACTURE 4 0.0009
279 STENT PLACEMENT 7 0.0009
280 EYE OPERATION 4 0.0009
281 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
282 RENAL FUNCTION TEST ABNORMAL 4 0.0009
283 ROSACEA 4 0.0009
284 DECREASED INTEREST 5 0.0008
285 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 5 0.0008
286 CARDIAC PACEMAKER INSERTION 5 0.0008
287 PELVIC PAIN 15 0.0008
288 EYE IRRITATION 47 0.0008
289 KIDNEY INFECTION 16 0.0008
290 CARDIAC OPERATION 7 0.0008
291 FOOT DEFORMITY 9 0.0008
292 FREEZING PHENOMENON 3 0.0008
293 PYELONEPHRITIS 7 0.0008
294 THROAT CLEARING 3 0.0008
295 FLUID INTAKE REDUCED 4 0.0008
296 PEMPHIGOID 6 0.0008
297 CATHETER SITE INFECTION 3 0.0008
298 FACE INJURY 3 0.0008
299 APHONIA 11 0.0008
300 TOE AMPUTATION 4 0.0008
301 SCREAMING 5 0.0008
302 GASTRIC INFECTION 3 0.0008
303 HIP ARTHROPLASTY 12 0.0008
304 OESOPHAGEAL DISORDER 3 0.0008
305 AORTIC ARTERIOSCLEROSIS 2 0.0008
306 CONCUSSION 6 0.0008
307 OROPHARYNGEAL DISCOMFORT 7 0.0008
308 DELUSION 12 0.0008
309 PELVIC FRACTURE 6 0.0008
310 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
311 PERIPHERAL SWELLING 117 0.0008
312 IRON DEFICIENCY ANAEMIA 7 0.0008
313 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
314 HYPERPHAGIA 3 0.0008
315 BALANCE DISORDER 65 0.0008
316 FUNGAL SKIN INFECTION 3 0.0007
317 DECREASED ACTIVITY 8 0.0007
318 NEPHROLITHIASIS 34 0.0007
319 FRACTURE 14 0.0007
320 BACK DISORDER 12 0.0007
321 TRIGGER FINGER 3 0.0007
322 IMPAIRED GASTRIC EMPTYING 10 0.0007
323 POLYURIA 6 0.0007
324 DIPLOPIA 19 0.0007
325 NONSPECIFIC REACTION 4 0.0007
326 LOWER LIMB FRACTURE 14 0.0007
327 LACRIMATION INCREASED 22 0.0007
328 FLUSHING 74 0.0007
329 ASTHENOPIA 4 0.0007
330 FALL 242 0.0007
331 GLAUCOMA 14 0.0007
332 DROOLING 5 0.0007
333 BLOOD PRESSURE INCREASED 110 0.0007
334 DYSSTASIA 21 0.0007
335 PHARYNGEAL SWELLING 7 0.0007
336 HIP FRACTURE 23 0.0007
337 OROPHARYNGEAL PAIN 66 0.0007
338 CHROMATURIA 16 0.0007
339 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
340 FEELING HOT 43 0.0007
341 HYPERSOMNIA 20 0.0007
342 DEVICE OPERATIONAL ISSUE 3 0.0007
343 RESPIRATORY TRACT CONGESTION 11 0.0007
344 NEOPLASM MALIGNANT 46 0.0007
345 DYSKINESIA 28 0.0007
346 EYELID PTOSIS 7 0.0007
347 DRY THROAT 7 0.0007
348 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 33 0.0007
349 DIARRHOEA 440 0.0007
350 PNEUMONIA ASPIRATION 17 0.0007
351 RHINITIS ALLERGIC 3 0.0007
352 FEELING DRUNK 5 0.0007
353 EYE SWELLING 25 0.0007
354 ERUCTATION 13 0.0007
355 MACULAR DEGENERATION 8 0.0007
356 EYE DISORDER 22 0.0007
357 SNEEZING 15 0.0007
358 HEADACHE 419 0.0007
359 HYPOAESTHESIA ORAL 10 0.0007
360 ADVERSE EVENT 61 0.0007
361 PLATELET COUNT ABNORMAL 4 0.0007
362 LIP DRY 6 0.0007
363 GAIT INABILITY 22 0.0007
364 CEREBRAL INFARCTION 16 0.0007
365 UROSEPSIS 6 0.0006
366 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
367 PRODUCTIVE COUGH 31 0.0006
368 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
369 PIGMENTATION DISORDER 4 0.0006
370 DIARRHOEA HAEMORRHAGIC 6 0.0006
371 PRE-EXISTING CONDITION IMPROVED 4 0.0006
372 TIBIA FRACTURE 3 0.0006
373 BLOOD CREATININE DECREASED 2 0.0006
374 BLOOD SODIUM DECREASED 12 0.0006
375 FLATULENCE 36 0.0006
376 SPUTUM DISCOLOURED 6 0.0006
377 HEAD INJURY 20 0.0006
378 ENDOMETRIOSIS 3 0.0006
379 BILE DUCT STONE 2 0.0006
380 SCIATICA 10 0.0006
381 EYE PRURITUS 21 0.0006
382 OCULAR DISCOMFORT 7 0.0006
383 VULVOVAGINAL PAIN 3 0.0006
384 MUSCLE TIGHTNESS 10 0.0006
385 PRODUCT DOSE OMISSION ISSUE 181 0.0006
386 DIVERTICULITIS 17 0.0006
387 ABNORMAL FAECES 5 0.0006
388 SLEEP DISORDER 43 0.0006
389 ORAL CANDIDIASIS 8 0.0006
390 HOSPICE CARE 6 0.0006
391 INFLAMMATORY MARKER INCREASED 3 0.0006
392 THERAPEUTIC RESPONSE SHORTENED 20 0.0006
393 FUNGAL INFECTION 20 0.0006
394 CORONARY ARTERIAL STENT INSERTION 3 0.0006
395 VITAMIN D DECREASED 5 0.0006
396 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
397 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
398 POOR VENOUS ACCESS 6 0.0006
399 COUGH 162 0.0006
400 SKIN SWELLING 5 0.0006
401 COVID-19 101 0.0006
402 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
403 RESTLESSNESS 21 0.0006
404 WEIGHT FLUCTUATION 6 0.0006
405 DEFAECATION URGENCY 4 0.0006
406 GROIN PAIN 5 0.0006
407 EAR PAIN 11 0.0006
408 PULMONARY TOXICITY 4 0.0006
409 THERAPY CESSATION 29 0.0006
410 HEAD DISCOMFORT 10 0.0006
411 CHOKING 11 0.0006
412 IRRITABLE BOWEL SYNDROME 12 0.0006
413 RENAL DISORDER 26 0.0006
414 INJECTION SITE DISCHARGE 3 0.0006
415 COGNITIVE DISORDER 26 0.0006
416 DISORIENTATION 22 0.0006
417 MUSCLE ATROPHY 7 0.0006
418 PRESCRIBED UNDERDOSE 11 0.0006
419 SPINAL FRACTURE 11 0.0005
420 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
421 DELIRIUM 19 0.0005
422 ATRIAL FIBRILLATION 53 0.0005
423 PROSTATIC DISORDER 3 0.0005
424 ABDOMINAL DISCOMFORT 91 0.0005
425 DENTAL CARIES 6 0.0005
426 PSYCHIATRIC SYMPTOM 4 0.0005
427 BLOOD PRESSURE FLUCTUATION 13 0.0005
428 LIP SWELLING 18 0.0005
429 BLOOD UREA INCREASED 9 0.0005
430 COLON CANCER 8 0.0005
431 MUSCULAR WEAKNESS 61 0.0005
432 MALNUTRITION 6 0.0005
433 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
434 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 107 0.0005
435 OCULAR HYPERAEMIA 25 0.0005
436 CARDIAC VALVE DISEASE 3 0.0005
437 RED BLOOD CELL COUNT DECREASED 15 0.0005
438 SWELLING FACE 34 0.0005
439 POST PROCEDURAL COMPLICATION 10 0.0005
440 MOUTH SWELLING 3 0.0005
441 OSTEOARTHRITIS 22 0.0005
442 HYPERVENTILATION 3 0.0005
443 HERNIA 10 0.0005
444 INSOMNIA 137 0.0005
445 ABDOMINAL PAIN LOWER 13 0.0005
446 JOINT SWELLING 62 0.0005
447 GAIT DISTURBANCE 98 0.0005
448 FLUID RETENTION 26 0.0005
449 NASOPHARYNGITIS 94 0.0005
450 VITREOUS FLOATERS 5 0.0005
451 BRADYKINESIA 3 0.0005
452 CONFUSIONAL STATE 82 0.0005
453 ORAL DISCOMFORT 7 0.0005
454 RENAL CYST 4 0.0005
455 MULTIPLE SCLEROSIS 24 0.0005
456 ABDOMINAL PAIN UPPER 103 0.0005
457 VISION BLURRED 68 0.0005
458 DYSPHAGIA 47 0.0005
459 RESTLESS LEGS SYNDROME 9 0.0005
460 TREATMENT NONCOMPLIANCE 27 0.0005
461 TASTE DISORDER 10 0.0005
462 POST PROCEDURAL INFECTION 4 0.0005
463 SLUGGISHNESS 5 0.0005
464 MEMORY IMPAIRMENT 67 0.0005
465 SMALL INTESTINAL OBSTRUCTION 6 0.0005
466 DIZZINESS 243 0.0005
467 EAR DISCOMFORT 5 0.0005
468 ESCHERICHIA INFECTION 4 0.0005
469 SCOLIOSIS 3 0.0005
470 SPINAL COMPRESSION FRACTURE 4 0.0005
471 ARTHRITIS 38 0.0005
472 EYE DISCHARGE 5 0.0005
473 GASTROINTESTINAL DISORDER 43 0.0005
474 SECRETION DISCHARGE 6 0.0005
475 ABDOMINAL DISTENSION 50 0.0005
476 DYSPHONIA 28 0.0005
477 NASAL DRYNESS 3 0.0005
478 PHOTOPHOBIA 9 0.0005
479 VERTIGO 29 0.0005
480 CONDITION AGGRAVATED 144 0.0005
481 JOINT DISLOCATION 5 0.0005
482 SLEEP APNOEA SYNDROME 9 0.0005
483 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
484 BACK PAIN 109 0.0005
485 JOINT INJURY 10 0.0005
486 PROCTALGIA 3 0.0005
487 POOR QUALITY SLEEP 10 0.0005
488 PRURITUS 177 0.0005
489 BONE CANCER 2 0.0005
490 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
491 PULMONARY THROMBOSIS 5 0.0005
492 BLOOD CALCIUM INCREASED 4 0.0005
493 SPINAL OSTEOARTHRITIS 4 0.0005
494 TOOTH INFECTION 6 0.0005
495 GASTROINTESTINAL PAIN 5 0.0005
496 CORONAVIRUS INFECTION 3 0.0005
497 PRODUCT COMMUNICATION ISSUE 4 0.0005
498 ERYTHEMA 93 0.0005
499 THERAPY PARTIAL RESPONDER 7 0.0004
500 ORAL PAIN 10 0.0004
501 BRONCHITIS 33 0.0004
502 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
503 FREQUENT BOWEL MOVEMENTS 12 0.0004
504 PRODUCT TASTE ABNORMAL 6 0.0004
505 EYE INFECTION 5 0.0004
506 TOOTHACHE 8 0.0004
507 LIMB INJURY 12 0.0004
508 PNEUMOTHORAX 7 0.0004
509 ABNORMAL LOSS OF WEIGHT 3 0.0004
510 SPEECH DISORDER 23 0.0004
511 INTERNAL HAEMORRHAGE 5 0.0004
512 ECCHYMOSIS 3 0.0004
513 BLOOD PRESSURE DECREASED 29 0.0004
514 CONTUSION 42 0.0004
515 ONYCHOCLASIS 3 0.0004
516 PNEUMONIA BACTERIAL 4 0.0004
517 RESPIRATION ABNORMAL 3 0.0004
518 FEELING ABNORMAL 104 0.0004
519 LYMPHOEDEMA 3 0.0004
520 HYPERSENSITIVITY 80 0.0004
521 HYPOMAGNESAEMIA 6 0.0004
522 PERSONALITY CHANGE 4 0.0004
523 COORDINATION ABNORMAL 6 0.0004
524 EXTRASYSTOLES 3 0.0004
525 MASS 6 0.0004
526 ERYTHEMA MULTIFORME 4 0.0004
527 BACTERIAL INFECTION 8 0.0004
528 CARPAL TUNNEL SYNDROME 6 0.0004
529 PAPULE 3 0.0004
530 RASH PRURITIC 23 0.0004
531 COVID-19 PNEUMONIA 5 0.0004
532 THERMAL BURN 3 0.0004
533 SPINAL DISORDER 4 0.0004
534 RESPIRATORY TRACT INFECTION 11 0.0004
535 RETINAL HAEMORRHAGE 3 0.0004
536 PRODUCT PACKAGING ISSUE 4 0.0004
537 ECZEMA 22 0.0004
538 PRODUCT SUPPLY ISSUE 3 0.0004
539 COAGULOPATHY 7 0.0004
540 HYPERLIPIDAEMIA 5 0.0004
541 MUSCLE RIGIDITY 5 0.0004
542 WRIST FRACTURE 5 0.0004
543 PARAESTHESIA ORAL 6 0.0004
544 APATHY 6 0.0004
545 VITAMIN D DEFICIENCY 4 0.0004
546 OXYGEN SATURATION DECREASED 23 0.0004
547 ORAL DISORDER 3 0.0004
548 COELIAC DISEASE 4 0.0004
549 HYPOPHOSPHATAEMIA 3 0.0004
550 LIGAMENT SPRAIN 4 0.0004
551 HAEMATOCRIT DECREASED 8 0.0004
552 ILEUS 5 0.0004
553 ORTHOSTATIC HYPOTENSION 7 0.0004
554 HEPATIC FUNCTION ABNORMAL 15 0.0004
555 UPPER LIMB FRACTURE 8 0.0004
556 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
557 DERMATITIS ALLERGIC 5 0.0004
558 SOMNOLENCE 80 0.0004
559 FATIGUE 308 0.0004
560 FEELING COLD 11 0.0004
561 FEEDING DISORDER 8 0.0004
562 RASH 171 0.0004
563 HYPOPHAGIA 10 0.0004
564 ADVERSE DRUG REACTION 35 0.0004
565 ROTATOR CUFF SYNDROME 5 0.0004
566 OSTEOPOROSIS 16 0.0004
567 ATRIOVENTRICULAR BLOCK 3 0.0004
568 ANKLE FRACTURE 6 0.0004
569 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
570 DEATH 332 0.0004
571 ANGIOEDEMA 17 0.0004
572 GASTROINTESTINAL INFLAMMATION 3 0.0004
573 DRY SKIN 51 0.0004
574 URTICARIA 64 0.0004
575 DERMATITIS 8 0.0004
576 PULMONARY CONGESTION 5 0.0004
577 NASAL DISCOMFORT 3 0.0004
578 PRODUCT PRESCRIBING ERROR 9 0.0004
579 HALLUCINATION, AUDITORY 6 0.0004
580 CELLULITIS 19 0.0004
581 NECK PAIN 21 0.0004
582 NIGHTMARE 13 0.0004
583 BREAST PAIN 4 0.0004
584 BLOOD DISORDER 3 0.0004
585 BLISTER 21 0.0004
586 MIOSIS 3 0.0004
587 MOVEMENT DISORDER 12 0.0004
588 HEART RATE INCREASED 37 0.0004
589 QUALITY OF LIFE DECREASED 5 0.0004
590 RASH MACULAR 13 0.0004
591 INTERSTITIAL LUNG DISEASE 18 0.0004
592 INTESTINAL OBSTRUCTION 14 0.0004
593 WHEEZING 22 0.0004
594 MUSCLE DISORDER 3 0.0004
595 PRESYNCOPE 9 0.0004
596 BEHAVIOUR DISORDER 2 0.0004
597 THROAT TIGHTNESS 10 0.0004
598 BLOOD POTASSIUM INCREASED 6 0.0004
599 FOOT FRACTURE 7 0.0004
600 OEDEMA PERIPHERAL 45 0.0004
601 HYPERTENSION 78 0.0004
602 SEPSIS 41 0.0004
603 ASPIRATION 4 0.0004
604 BLOOD GLUCOSE FLUCTUATION 4 0.0004
605 NAUSEA 288 0.0004
606 CEREBRAL HAEMORRHAGE 13 0.0004
607 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
608 ASTHENIA 136 0.0004
609 EMBOLISM 3 0.0004
610 HEMIPLEGIA 3 0.0004
611 WOUND 10 0.0004
612 BURNING SENSATION 25 0.0004
613 SENSATION OF FOREIGN BODY 3 0.0004
614 BLOOD CALCIUM DECREASED 4 0.0004
615 ACCIDENTAL OVERDOSE 13 0.0004
616 DEVICE OCCLUSION 5 0.0004
617 SEIZURE 41 0.0004
618 MUSCULOSKELETAL STIFFNESS 31 0.0004
619 PAIN IN JAW 10 0.0004
620 PALPITATIONS 41 0.0003
621 PARANOIA 6 0.0003
622 LETHARGY 20 0.0003
623 CARDIAC MURMUR 3 0.0003
624 DYSPEPSIA 34 0.0003
625 DEHYDRATION 46 0.0003
626 ELECTROLYTE IMBALANCE 4 0.0003
627 SKIN EXFOLIATION 29 0.0003
628 PRODUCT USE IN UNAPPROVED INDICATION 85 0.0003
629 UNDERDOSE 25 0.0003
630 SWELLING 32 0.0003
631 EAR INFECTION 9 0.0003
632 MUSCLE SPASMS 62 0.0003
633 BLOOD IRON DECREASED 4 0.0003
634 CEREBROVASCULAR ACCIDENT 57 0.0003
635 CATARACT 20 0.0003
636 GASTROINTESTINAL INFECTION 3 0.0003
637 GOUT 6 0.0003
638 THROAT IRRITATION 15 0.0003
639 MOBILITY DECREASED 24 0.0003
640 INFLUENZA 37 0.0003
641 LOCALISED INFECTION 8 0.0003
642 OSTEOPENIA 5 0.0003
643 NEURALGIA 8 0.0003
644 AGITATION 24 0.0003
645 CYTOPENIA 4 0.0003
646 INCREASED TENDENCY TO BRUISE 3 0.0003
647 TREMOR 54 0.0003
648 THYROID DISORDER 5 0.0003
649 PNEUMONIA 105 0.0003
650 FEMUR FRACTURE 10 0.0003
651 FAECES DISCOLOURED 7 0.0003
652 VISUAL IMPAIRMENT 40 0.0003
653 MENTAL DISORDER 14 0.0003
654 HEPATIC ENCEPHALOPATHY 3 0.0003
655 TOOTH EXTRACTION 4 0.0003
656 PRODUCT PRESCRIBING ISSUE 7 0.0003
657 CARDIAC DISORDER 30 0.0003
658 SWOLLEN TONGUE 10 0.0003
659 AGGRESSION 16 0.0003
660 PAIN IN EXTREMITY 94 0.0003
661 DYSARTHRIA 12 0.0003
662 PRODUCT COMPLAINT 8 0.0003
663 FEELING JITTERY 6 0.0003
664 INCREASED APPETITE 6 0.0003
665 RASH ERYTHEMATOUS 15 0.0003
666 OEDEMA 17 0.0003
667 HERPES ZOSTER 18 0.0003
668 HEART RATE DECREASED 11 0.0003
669 SINUSITIS 32 0.0003
670 AFFECT LABILITY 3 0.0003
671 PANCREATITIS ACUTE 7 0.0003
672 CARDIAC FAILURE 25 0.0003
673 INFECTION 45 0.0003
674 ATELECTASIS 3 0.0003
675 HIATUS HERNIA 4 0.0003
676 INJECTION SITE INDURATION 4 0.0003
677 AUTOIMMUNE DISORDER 3 0.0003
678 AMNESIA 20 0.0003
679 SKIN FISSURES 6 0.0003
680 BLOOD CREATININE INCREASED 20 0.0003
681 BRADYPHRENIA 2 0.0003
682 THERAPY CHANGE 3 0.0003
683 CHOLELITHIASIS 10 0.0003
684 LOSS OF CONSCIOUSNESS 39 0.0003
685 SARS-COV-2 TEST POSITIVE 4 0.0003
686 PAIN 186 0.0003
687 PHOTOSENSITIVITY REACTION 5 0.0003
688 CHEST DISCOMFORT 31 0.0003
689 DRUG INTERACTION 48 0.0003
690 RESPIRATORY DISORDER 9 0.0003
691 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
692 ARTHRALGIA 124 0.0003
693 FULL BLOOD COUNT DECREASED 6 0.0003
694 PRODUCT PHYSICAL ISSUE 6 0.0003
695 PRODUCT ADMINISTRATION ERROR 6 0.0003
696 DEPRESSION 67 0.0003
697 NEUROPATHY PERIPHERAL 28 0.0003
698 MIGRAINE 28 0.0003
699 BLOOD TESTOSTERONE DECREASED 2 0.0003
700 CORONARY ARTERY OCCLUSION 4 0.0003
701 UNEVALUABLE EVENT 22 0.0003
702 WEIGHT INCREASED 65 0.0003
703 BONE PAIN 17 0.0003
704 VENTRICULAR EXTRASYSTOLES 3 0.0003
705 ARTHROPATHY 16 0.0003
706 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15 0.0003
707 ROAD TRAFFIC ACCIDENT 12 0.0003
708 BLOOD TEST ABNORMAL 4 0.0003
709 DECREASED APPETITE 66 0.0003
710 COLD SWEAT 5 0.0003
711 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
712 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
713 DRUG ERUPTION 5 0.0003
714 HYPOTHYROIDISM 9 0.0003
715 EATING DISORDER 6 0.0003
716 RETCHING 6 0.0003
717 DYSPNOEA 159 0.0003
718 HYPOAESTHESIA 42 0.0003
719 DRUG INTOLERANCE 27 0.0003
720 LIVER FUNCTION TEST INCREASED 6 0.0003
721 HYPERHIDROSIS 36 0.0003
722 SUBDURAL HAEMATOMA 4 0.0003
723 SKIN CANCER 6 0.0003
724 DISTURBANCE IN ATTENTION 15 0.0003
725 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
726 HYPERTHYROIDISM 4 0.0003
727 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
728 BIPOLAR DISORDER 3 0.0003
729 OESOPHAGITIS 3 0.0003
730 ARRHYTHMIA 13 0.0003
731 HOSPITALISATION 42 0.0003
732 ANAPHYLACTIC REACTION 15 0.0003
733 PSYCHOTIC DISORDER 8 0.0003
734 WEIGHT DECREASED 75 0.0003
735 HEPATIC STEATOSIS 5 0.0003
736 RASH PAPULAR 6 0.0003
737 HEPATIC CIRRHOSIS 5 0.0003
738 GASTRITIS 7 0.0003
739 HEART RATE IRREGULAR 6 0.0003
740 MYALGIA 45 0.0003
741 THERAPEUTIC RESPONSE DECREASED 16 0.0003
742 SCAB 3 0.0003
743 HAEMATURIA 9 0.0003
744 CARDIAC FAILURE CONGESTIVE 21 0.0003
745 TINNITUS 12 0.0003
746 ANXIETY 74 0.0003
747 MALAISE 114 0.0003
748 LIMB DISCOMFORT 8 0.0003
749 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
750 AFFECTIVE DISORDER 2 0.0003
751 MENTAL STATUS CHANGES 7 0.0003
752 MYOCLONUS 3 0.0003
753 HAEMOPTYSIS 7 0.0003
754 ATRIAL FLUTTER 2 0.0003
755 RENAL IMPAIRMENT 21 0.0002
756 ALOPECIA 49 0.0002
757 CYTOKINE RELEASE SYNDROME 5 0.0002
758 NERVOUSNESS 13 0.0002
759 BURSITIS 3 0.0002
760 DEPRESSED MOOD 13 0.0002
761 PULMONARY OEDEMA 11 0.0002
762 ASPHYXIA 2 0.0002
763 INJECTION SITE URTICARIA 6 0.0002
764 MULTIPLE FRACTURES 4 0.0002
765 MANIA 4 0.0002
766 STAPHYLOCOCCAL INFECTION 8 0.0002
767 GENERALISED OEDEMA 3 0.0002
768 ACUTE CORONARY SYNDROME 2 0.0002
769 INCORRECT DOSE ADMINISTERED 55 0.0002
770 EPISTAXIS 18 0.0002
771 AGEUSIA 6 0.0002
772 SKIN DISORDER 8 0.0002
773 CANDIDA INFECTION 4 0.0002
774 ANGER 8 0.0002
775 THROMBOSIS 19 0.0002
776 PARAESTHESIA 37 0.0002
777 INTRAOCULAR PRESSURE INCREASED 3 0.0002
778 HEPATIC ENZYME INCREASED 16 0.0002
779 ANAPHYLACTIC SHOCK 6 0.0002
780 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
781 NO ADVERSE EVENT 42 0.0002
782 BLOOD MAGNESIUM DECREASED 2 0.0002
783 BLOOD GLUCOSE DECREASED 11 0.0002
784 DERMATITIS ATOPIC 12 0.0002
785 ADVERSE REACTION 3 0.0002
786 TOOTH DISORDER 5 0.0002
787 EYE HAEMORRHAGE 3 0.0002
788 DRUG-INDUCED LIVER INJURY 7 0.0002
789 EXTRA DOSE ADMINISTERED 9 0.0002
790 GASTROENTERITIS VIRAL 4 0.0002
791 GINGIVAL BLEEDING 3 0.0002
792 PERIPHERAL COLDNESS 3 0.0002
793 BRAIN NEOPLASM 2 0.0002
794 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
795 ABNORMAL DREAMS 6 0.0002
796 MUSCLE TWITCHING 5 0.0002
797 BLOOD GLUCOSE ABNORMAL 4 0.0002
798 PROCEDURAL PAIN 6 0.0002
799 PERICARDIAL EFFUSION 5 0.0002
800 RHABDOMYOLYSIS 9 0.0002
801 DISCOMFORT 13 0.0002
802 DYSPNOEA EXERTIONAL 8 0.0002
803 INFUSION RELATED REACTION 14 0.0002
804 PROTEINURIA 4 0.0002
805 BRONCHOSPASM 3 0.0002
806 PARALYSIS 3 0.0002
807 PULMONARY FIBROSIS 4 0.0002
808 PRESCRIBED OVERDOSE 4 0.0002
809 HYPOKINESIA 3 0.0002
810 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
811 NEEDLE ISSUE 6 0.0002
812 FIBROMYALGIA 5 0.0002
813 HAEMORRHOIDS 4 0.0002
814 ORAL HERPES 4 0.0002
815 BLADDER CANCER 12 0.0002
816 LABORATORY TEST ABNORMAL 6 0.0002
817 LIVER DISORDER 9 0.0002
818 HAEMORRHAGE INTRACRANIAL 3 0.0002
819 OFF LABEL USE 175 0.0002
820 HYPERKALAEMIA 7 0.0002
821 BRAIN INJURY 2 0.0002
822 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
823 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
824 ABDOMINAL PAIN 46 0.0002
825 BLINDNESS 8 0.0002
826 CHILLS 23 0.0002
827 BODY TEMPERATURE INCREASED 4 0.0002
828 VOMITING 92 0.0002
829 MYOCARDIAL INFARCTION 34 0.0002
830 ASTHMA 22 0.0002
831 LUNG NEOPLASM MALIGNANT 8 0.0002
832 TENDONITIS 3 0.0002
833 HAEMATOMA 5 0.0002
834 EXPOSURE VIA SKIN CONTACT 5 0.0002
835 CRYING 7 0.0002
836 BASAL CELL CARCINOMA 3 0.0002
837 DEAFNESS 5 0.0002
838 JOINT STIFFNESS 5 0.0002
839 MOUTH ULCERATION 4 0.0002
840 DEVICE ISSUE 17 0.0002
841 ULCER 3 0.0002
842 SENSORY DISTURBANCE 3 0.0002
843 PROSTATE CANCER 15 0.0002
844 BLOOD GLUCOSE INCREASED 35 0.0002
845 HAEMOGLOBIN DECREASED 19 0.0002
846 BACK INJURY 2 0.0002
847 DIABETES MELLITUS 14 0.0002
848 LUNG DISORDER 9 0.0002
849 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
850 ACUTE KIDNEY INJURY 28 0.0002
851 INJECTION SITE SWELLING 14 0.0002
852 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
853 EXPIRED PRODUCT ADMINISTERED 6 0.0002
854 VIRAL INFECTION 6 0.0002
855 SYNCOPE 18 0.0002
856 PERICARDITIS 3 0.0002
857 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
858 ABNORMAL BEHAVIOUR 7 0.0002
859 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
860 DYSGEUSIA 13 0.0002
861 INFLAMMATION 9 0.0002
862 HAEMORRHAGE 18 0.0002
863 DEVICE USE ISSUE 3 0.0002
864 SYRINGE ISSUE 3 0.0002
865 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8 0.0002
866 CHRONIC KIDNEY DISEASE 13 0.0002
867 INFLUENZA LIKE ILLNESS 14 0.0002
868 HYPOTENSION 34 0.0002
869 GALLBLADDER DISORDER 3 0.0002
870 OSTEOMYELITIS 3 0.0002
871 APHASIA 5 0.0002
872 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
873 ADRENAL INSUFFICIENCY 2 0.0002
874 BONE DISORDER 3 0.0002
875 ILL-DEFINED DISORDER 10 0.0002
876 PLEURAL EFFUSION 10 0.0002
877 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
878 PYREXIA 55 0.0002
879 ACUTE RESPIRATORY FAILURE 3 0.0002
880 UNRESPONSIVE TO STIMULI 4 0.0002
881 HYPOKALAEMIA 7 0.0002
882 INJECTION SITE BRUISING 12 0.0002
883 INJECTION SITE PAIN 46 0.0001
884 BREAST CANCER FEMALE 4 0.0001
885 FEAR 4 0.0001
886 TYPE 2 DIABETES MELLITUS 5 0.0001
887 NEUTROPHIL COUNT DECREASED 6 0.0001
888 DISEASE RECURRENCE 7 0.0001
889 PNEUMONITIS 4 0.0001
890 MOOD ALTERED 4 0.0001
891 AKATHISIA 2 0.0001
892 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
893 SKIN LESION 4 0.0001
894 CHEST PAIN 27 0.0001
895 HYPONATRAEMIA 8 0.0001
896 BLINDNESS UNILATERAL 2 0.0001
897 TARDIVE DYSKINESIA 4 0.0001
898 PLATELET COUNT DECREASED 15 0.0001
899 SKIN BURNING SENSATION 10 0.0001
900 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
901 HYPERGLYCAEMIA 5 0.0001
902 INJECTION SITE PRURITUS 9 0.0001
903 THERAPY NON-RESPONDER 6 0.0001
904 PANCREATITIS 7 0.0001
905 BRADYCARDIA 7 0.0001
906 STOMATITIS 8 0.0001
907 COLITIS 5 0.0001
908 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
909 SKIN IRRITATION 6 0.0001
910 INJECTION SITE RASH 4 0.0001
911 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
912 BLOOD CHOLESTEROL INCREASED 6 0.0001
913 ACUTE MYELOID LEUKAEMIA 2 0.0001
914 NERVOUS SYSTEM DISORDER 4 0.0001
915 MEDICATION ERROR 7 0.0001
916 MENTAL IMPAIRMENT 3 0.0001
917 DEVICE BREAKAGE 5 0.0001
918 DEVICE DIFFICULT TO USE 8 0.0001
919 FEBRILE NEUTROPENIA 8 0.0001
920 ERECTILE DYSFUNCTION 3 0.0001
921 IRRITABILITY 7 0.0001
922 SKIN ULCER 3 0.0001
923 PULMONARY EMBOLISM 11 0.0001
924 PSORIASIS 15 0.0001
925 RHEUMATOID ARTHRITIS 13 0.0001
926 PRODUCT STORAGE ERROR 10 0.0001
927 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
928 BLOOD BILIRUBIN INCREASED 3 0.0001
929 SKIN DISCOLOURATION 5 0.0001
930 DEEP VEIN THROMBOSIS 7 0.0001
931 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
932 RENAL CANCER 5 0.0001
933 ANAEMIA 20 0.0001
934 ANGINA PECTORIS 3 0.0001
935 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
936 PANCREATIC CARCINOMA 3 0.0001
937 PLASMA CELL MYELOMA 4 0.0001
938 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
939 DISEASE PROGRESSION 12 0.0001
940 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
941 BLOOD POTASSIUM DECREASED 3 0.0001
942 EPILEPSY 3 0.0001
943 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
944 OVERDOSE 21 0.0001
945 EMOTIONAL DISORDER 3 0.0001
946 BONE DENSITY DECREASED 3 0.0001
947 MUSCULOSKELETAL PAIN 5 0.0001
948 INTENTIONAL OVERDOSE 6 0.0001
949 VAGINAL HAEMORRHAGE 4 0.0001
950 SEPTIC SHOCK 4 0.0001
951 INTENTIONAL PRODUCT MISUSE 8 0.0001
952 IMPAIRED HEALING 3 0.0001
953 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
954 EMOTIONAL DISTRESS 11 0.0001
955 HAEMATOCHEZIA 5 0.0001
956 TACHYCARDIA 8 0.0001
957 PANCYTOPENIA 5 0.0001
958 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
959 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
960 GASTRIC DISORDER 3 0.0001
961 SUICIDAL IDEATION 8 0.0001
962 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
963 INJECTION SITE REACTION 6 0.0001
964 PRODUCT SUBSTITUTION ISSUE 5 0.0001
965 NEOPLASM PROGRESSION 3 0.0001
966 DEVICE MALFUNCTION 6 0.0001
967 INJURY 6 0.0001
968 HYPOXIA 3 0.0001
969 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
970 PRODUCT ADHESION ISSUE 3 0.0001
971 TOXICITY TO VARIOUS AGENTS 14 0.0001
972 SUICIDE ATTEMPT 5 0.0001
973 C-REACTIVE PROTEIN INCREASED 3 0.0001
974 RESPIRATORY FAILURE 6 0.0001
975 DRUG DOSE OMISSION BY DEVICE 6 0.0001
976 RENAL FAILURE 10 0.0001
977 INJECTION SITE ERYTHEMA 9 0.0001
978 RECTAL HAEMORRHAGE 3 0.0001
979 DEVICE LEAKAGE 3 0.0001
980 DEVICE DISLOCATION 3 0.0001
981 ASCITES 2 0.0001
982 CARDIAC ARREST 5 0.0001
983 THROMBOCYTOPENIA 5 0.0000
984 PRODUCT QUALITY ISSUE 6 0.0000
985 NEUTROPENIA 6 0.0000
986 BREAST CANCER 4 0.0000
987 INJECTION SITE HAEMORRHAGE 3 0.0000
988 TREATMENT FAILURE 3 0.0000
989 ACNE 2 0.0000